Animas Corporation announced today further promising results from the second phase of human clinical trials of a first-generation closed-loop insulin delivery system in development. Data investigating the predictive Hypoglycemia-Hyperglycemia Minimizer (HHM) System demonstrated that the system is capable of maintaining safe glucose levels overnight.
The brain-preserving cooling treatment known as therapeutic hypothermia is rarely being used in patients who suffer cardiac arrest while in the hospital, despite its proven potential to improve survival and neurological function, researchers from the Perelman School of Medicine at the University of Pennsylvania report in the June issue of Critical Care Medicine.
A new study reports that the use of a quarterly report card is associated with improved colonoscopy quality indicators. Endoscopists at the Roudebush Veterans Affairs Medical Center in Indianapolis, Ind., who participated in the study showed an overall adjusted adenoma (precancerous polyp) detection rate increase from 44.7 percent to 53.9 percent, and a cecal intubation rate increase from 95.6 percent to 98.1 percent.
When high school football coach Kevin Bella needs an intense, heart-to-heart with a player, he goes home and sits on his couch. That's because Bella, who is deaf, communicates with his hearing players most clearly with a new technology that brings a live sign language interpreter to his television screen.
ALRT's Internet-Based Glucose Monitoring Platform Compares Favorably with Medtronic's Continuous Glucose Monitoring SystemJune 24, 2013 8:18 am | by The Associated Press | Comments
This weekend, ALR Technologies announced at the American Diabetes Association meeting in Chicago that the A1c reduction in insulin-requiring patients with type 2 diabetes mellitus who managed their blood glucose using ALRT's Internet-Based Glucose Monitoring (IBGMS) platform, "Health-e-Connect", demonstrated comparable results to patients using Medtronic's "Guardian REAL-Time Continuous Glucose Monitoring System" (RT-CGM).
St. Jude Medical, Inc., a global medical device company, today announced CE Mark approval of its next-generation quadripolar device, the Quadra Assura MP ™ cardiac resynchronization therapy defibrillator (CRT-D). Built upon the company’s first-to-market Quadripolar Pacing System, the Quadra Assura MP CRT-D features MultiPoint ™ Pacing (MPP) technology that enables physicians to pace multiple locations on the left side of the heart.
Evergreen Medical Technologies Launches Integrated Lead to Pulse Generator Interconnect System for Implantable NeurostimulatorsJune 21, 2013 2:46 pm | by Business Wire | RMS, Bal Seal Engineering, Inc. | Comments
Evergreen Medical Technologies has launched the Encompass Lead-Interconnect System, the first pretested integrated lead-interconnect system designed for implantable neurostimulator pulse generator (IPG) devices. The Encompass, enabled by Bal Seal Engineering’s SYGNUS® implantable contact system and rms Company’s premolded 16-channel header technology, saves development time and costs for neurostimulation device companies.
Norman Noble, Inc., a leading contract manufacturer of medical devices and implants, today launched a new virtual tour of its manufacturing facilities on its web site. From its dedicated prototype departments, to its expansive stent manufacturing operations, to its Nitinol processing services, and much more, the tour gives Norman Noble’s OEM customers worldwide an up-close look...
BIOTRONIK has announced the European market launch of its Ilesto 7 Series today. Ilesto 7 is the world’s first DF4 ICD/CRT series approved for MRI, and includes one of the world’s smallest ICDs while also offering the greatest longevity—up to 11.5 years for the single chamber ICD.
Neuroscientists may soon be modern-day harpooners, snaring individual brain-cell signals instead of whales with tiny spears made of carbon nanotubes. The new brain cell spear is a millimeter long, only a few nanometers wide and harnesses the superior electromechanical properties of carbon nanotubes to capture electrical signals from individual neurons.
Duke University biomedical engineers and genome researchers have developed a proof-of-principle approach using light to detect infections before patients show symptoms. The approach was demonstrated in human samples, and researchers are now developing the technique for placement on a chip, which could provide fast, simple and reliable information about a patient.
A landmark three-dimensional (3-D) digital reconstruction of a complete human brain, called the BigBrain, now for the first time shows the brain anatomy in microscopic detail—at a spatial resolution of 20 microns, smaller than the size of one fine strand of hair—exceeding that of existing reference brains presently in the public domain.
Lumosity, the leading brain training company, today announced a new web-based, big data methodology for conducting human cognitive performance research. Lumosity's research platform, the Human Cognition Project, contains the world's largest and continuously growing dataset of human cognitive performance, which currently includes more than 40 million people who have been tracked for up to 6 years.
RegeneCure announced today the start of a clinical study using the company's proprietary AMCA Guided Bone Regeneration (GBR) Dental Membrane as a bone stimulating aid for patients requiring dental implants. A common problem encountered when patients have a tooth replaced with a dental implant is the lack of sufficient bone volume to house the implant.
Royal Philips (NYSE: PHG, AEX: PHIA) today announced new capabilities for its Iterative Model Reconstruction (IMR) technology, a knowledge-based iterative reconstruction technique, that will simultaneously bring enhanced benefits to clinicians and patients.